trans-[PtCl2(2-chloro-6-((2-methoxybenzyl)amino)-9-isopropylpurine)2] | 1062102-64-0

• 英文名称: trans-[PtCl2(2-chloro-6-((2-methoxybenzyl)amino)-9-isopropylpurine)2]
• CAS: 1062102-64-0；1061331-97-2
• 化学式: C₃₂H₃₆Cl₄N₁₀O₂Pt
• 分子量: 929.596
• InChiKey: YOBXIVRCGPMSME-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为产物：
  描述：

  2-chloro-6-((2-methoxybenzyl)amino)-9-isopropylpurine 以 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 生成 trans-[PtCl2(2-chloro-6-((2-methoxybenzyl)amino)-9-isopropylpurine)2]
  参考文献：
  名称：

  Preparation and cis-to-trans transformation study of square-planar [Pt(Ln)2Cl2] complexes bearing cytokinins derived from 6-benzylaminopurine (Ln) by view of NMR spectroscopy and X-ray crystallography

  摘要：

  Mononuclear, square-planar platinum(II) complexes involving derivatives of aromatic cytokinins as the ligands, and having the general formula cis-[Pt(L-n)(2)Cl-2] (1-3) and trans-[Pt(L-n)(2)Cl-2] (4-6), where n = 13, L-1 = 2-chloro-6-(benzylamino)-9-isopropylpurine, L-2 = 2-chloro-6-[(4-methoxybenzyl)amino]-9-isopropylpurine and L-3 = 2-chloro-6-[(2-methoxybenzyl)-amino]-9-isopropylpurine, have been synthesized and characterized by elemental analysis, MALDI-TOF mass, FT IR, H-1, C-13, N-15 and Pt-195 NMR spectral measurements. Dynamic cis-to-trans isomerization process of complex 1 in N,N'-dimethylformamide (DMF) has been investigated by means of multinuclear NMR spectroscopy. The solid-state structures of 1, 4 center dot (DMF)(2), and 5 have been determined by single crystal X-ray analysis. X-ray structures revealed that the heterocyclic ligands are coordinated to platinum via nitrogen atom N(7) in all the complexes studied. In vitro cytotoxicity of the prepared complexes against MCF7, G361, K562, and HOS has been evaluated. Owing to low solubility of the complexes in water, the cytotoxicity has been only tested up to 5 mu M concentration. Unfortunately, all complexes have been found to be non-cytotoxic in the accessible concentration range.

  DOI：

  10.1016/j.poly.2008.05.021